Dalhousie Multiple Sclerosis Research Unit

Halifax, Nova Scotia B3H 4K4

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis — Running, not enrolling
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed